IXICO CTO and Chief Business Officer Receive Share Options; CFO Reinvests in Company with Share Repurchase

In a clear endorsement of the company’s growth prospects, tech firm IXICO has awarded share options to two of its executives. The AIM-listed medical imaging analytics firm has reportedly provided chief technology officer Mark Austin and chief business officer James Chandler with 850,000 options to subscribe for ordinary shares of 1 pence each in the company.

Both Austin and Chandler are considered Persons Discharging Managerial Responsibility (PDMRs), a designation important under the Market Abuse Regulation. The options come with vesting criteria, designed to drive retention and annual share price growth over a three-year period. All options are subject to a hold period until the third anniversary of their award. The share price growth required to meet these criteria can be achieved either through an absolute annual compound growth rate of 40% over the three years, or a 40% increase relative to the previous year’s share price.

IXICO’s mission is to advance medicine and human health by transforming data into clinically meaningful information. Primarily, the company supports pharmaceutical firms throughout their clinical research process in neurological diseases such as Huntington’s, Parkinson’s, and Alzheimer’s diseases. Already renowned for their powerful data analytics and remote access technology platform, the company aims to lead in the application of artificial intelligence in medical image analysis.